In @jamacardiology.com , scientists show nearly 6 in 10 US vs 3 in 10 Japanese older adults with diabetes quit semaglutide shots w/in 1 year. Lower discontinuation in Japan points to impact of costs, supply issues jamanetwork.com/journals/jam...

Discontinuation of Semaglutide Among Older Adults With Diabetes in the US and Japan

This cohort study evaluates frequencies and predictors of discontinuation of injectable semaglutide in older adults with diabetes in the US and Japan.

jamanetwork.com

💻 #AI & #MachineLearning for Sepsis Diagnosis Researchers at Prenosis, @bidmcreseach.bsky.social & @harvardmed.bsky.social developed the Sepsis ImmunoScore, an AI tool that predicts patient risk & severity within 24 hours. Learn more in @ai.nejm.org ai.nejm.org/doi/full/10.... 5/

FDA-Authorized AI/ML Tool for Sepsis Prediction: Development and Validation

Sepsis is a life-threatening condition that demands prompt treatment for improved patient outcomes. Its heterogenous presentation makes early detection challenging, highlighting the need for effect...

ai.nejm.org

Scientists, academics, researchers: We’re excited to share that @altmetric.com is now tracking mentions of your research on Bluesky! 🧪

Altmetric@altmetric.com · 2y ago

There are already many articles for which there is more attention on Bluesky than on other comparable micro-blogging sites, meaning the academic community and the general public have clearly adopted Bluesky as one of its core places to disseminate and discuss new research. A Place of Joy.

BIDMC's Brian J. Carney, MD, and Richard L. Haspel, MD, & colleague describe how non-evidenced based policies regarding people with sickle cell trait can lead to unequal treatment in the US military and college athletics and beyond. www.nejm.org/doi/full/10....

Sickle Cell Trait, Inequity, and the Need for Change | NEJM

Because of misperceptions about risks, people with sickle cell trait in the United States may receive inequitable and potentially harmful treatment, with implications for autonomy, privacy, and ...

nejm.org

“Ensuring equitable access to these effective but high-cost medications, and supporting individuals so that they can stay on the therapy long-term, should be a priority for our clinicians and policymakers." said corresponding author Dhruv S. Kazi, MD, MS, www.bidmc.org/about-bidmc/...

"Authoritative tips for manuscript preparation" #Matter Edward Sargent shares ten tips on writing successful research articles. Open Access www.cell.com/matter/fullt...

Viewpoint from Sven Jordt and Sairam Jabba: California's Assembly Bill 3218 closes loopholes on flavored tobacco and synthetic nicotine, setting a potential model for other states and the FDA. ja.ma/4eXuHza